Patients Discontinuing Anti-Obesity Jabs Put On Weight Four Times Faster Compared to Those on Conventional Diets

A recent study indicates that individuals who come off new weight-loss injections like Mounjaro or Wegovy can put back on lost weight much more quickly than those who end traditional lifestyle plans.

Findings released in a prominent medical journal demonstrates that while overweight individuals frequently drop substantial amounts of their total mass while on the medication, the mass returns at an estimated rate of 0.8 kg per month upon discontinuation.

"Users purchasing such treatments should be cognizant of the potential of quick rebound weight gain when the treatment ends," cautioned researcher Dr. Susan Jebb.

This pace of recovery implies a reversion to original weight in about a year and a half.

Comparing Therapies

The research, which reviewed 37 of studies involving over 9,000 of participants, contrasted the effects of the injectable medications with conventional dieting.

Researchers point out that individuals who lose weight through diet and exercise generally have a less rapid weight regain—approximately 100 grams monthly—post-intervention.

The Reason for the Fast Rebound

Experts suggest the way of the drugs explains the accelerated rebound.

These medications copy a natural hormone called GLP-1, which controls hunger.

"Sustained high doses of GLP-1 levels far above than normal could lead to the system to produce less of its endogenous GLP-1, and could lessen sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher.

"Stopping of this medication results in appetite is no longer kept in check, making excessive eating much more probable."

An Ongoing Issue?

Medical guidelines suggest the injections for people with weight-linked medical conditions, alongside prescribed diet and exercise modifications.

Professionals argue that, considering the likelihood of weight regain, the therapy might need to be life-long.

This perspective is echoed by drug manufacturers, who note that the results "highlight the long-term character of obesity," akin to managing diseases like hypertension.

Patient Accounts

Individuals who have discontinued the jabs explain a sudden return of hunger.

"It was like something flipping and I was suddenly starving," recalled an individual.

This difficulty is compounded if patients have not developed lasting lifestyle or habit changes during therapy.

Widespread Use

Survey data indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with demand remaining high.

• Use is more common among females compared to males.
• The middle-aged demographic shows the highest level of interest.
• Many obtain the drugs through private healthcare rather than the NHS.

In conclusion, researchers stress that while the jabs are effective agents for weight loss, they are not a standalone cure and long-term success hinges on ongoing lifestyle support.